First UK patient receives pioneering CAR-T therapy for aggressive leukaemia

bbc.com

Oscar Murphy, 28, is the first UK patient to receive CAR-T therapy on the NHS for aggressive leukaemia. The pioneering "living drug" involves genetically modified immune cells targeting his cancer. This treatment, previously unavailable for his specific condition, offers hope for longer survival. CAR-T therapy has been extended to adults with B-cell acute lymphoblastic leukaemia, with around 50 patients expected to benefit annually.


With a significance score of 6.6, this news ranks in the top 0.1% of today's 31844 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: